3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neurofibromatosis 1
12
Neurofibroma, Plexiform
6
Carcinoma, Non-Small-Cell Lung
4
Neurofibrosarcoma
3
Neoplasms
3
Lung Neoplasms
3
Melanoma
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Pancreatic Neoplasms
1
Pain
1
Neoplasm Metastasis
1
Muscle Invasive Bladder Cancer
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Kidney Neoplasms
1
Gallbladder Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Astrocytoma
1
Advanced Non Small Cell Lung Cancer
1
Adenocarcinoma
1
Interventions
pembrolizumab
4
Cyclophosphamide
4
Radiotherapy
3
Cisplatin
3
fludarabine
2
Doxorubicin
2
Carboplatin
2
zimberelimab
1
olaparib
1
lenvatinib
1
envafolimab
1
avelumab
1
Thymectomy
1
Taxes
1
Sunitinib
1
Robotic Surgical Procedures
1
Ramucirumab
1
Radiotherapy, Adjuvant
1
Paclitaxel
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Etoposide
1
Drug Therapy
1
Chemoradiotherapy
1
Cetuximab
1
AP 1903 reagent
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thymoma
×
AZD 6244
×
1 year
×
Clear all
No trials found.